Brief: Biontech Commences Public Exchange Offer For All Outstanding Shares Of Curevac N.V.

CureVac NV

22/10/2025 11:50

Oct 22 (Reuters) - BIONTECH SE 22UAy.DE:

BIONTECH COMMENCES PUBLIC EXCHANGE OFFER FOR ALL OUTSTANDING SHARES OF CUREVAC N.V.

UNDER TERMS OF PURCHASE AGREEMENT, EACH CUREVAC SHARE WILL BE EXCHANGED FOR APPROXIMATELY $5.46 IN BIONTECH AMERICAN DEPOSITARY

CUREVAC SHAREHOLDERS RECEIVE APPROXIMATELY $5.46 IN BIONTECH AMERICAN DEPOSITARY SHARES FOR EACH CUREVAC SHARE

OFFER WILL EXPIRE AT 9:00 A.M. (NEW YORK CITY TIME) ON DECEMBER 3, 2025

OFFER IS SUBJECT TO VARIOUS CONDITIONS, INCLUDING AT LEAST 80% OF CUREVAC'S SHARES BEING TENDERED

AND CUREVAC WILL EFFECTUATE A CORPORATE REORGANIZATION OF CUREVAC AND ITS SUBSIDIARIES, RESULTING IN BIONTECH OWNING 100% OF CUREVAC'S BUSINESS

SUBJECT TO A COLLAR MECHANISM, SUCH THAT IF 10-DAY VOLUME WEIGHTED AVERAGE PRICE OF A BIONTECH ADS ENDING ON, AND INCLUDING, FIFTH BUSINESS DAY PRIOR TO CLOSING OF OFFER ("VWAP") IS GREATER THAN OR EQUAL TO $126.55, EACH CUREVAC SHARE WILL BE EXCHANGED ( "EXCHANGE RATIO") FOR 0.04318 OF A BIONTECH ADS

AND IF VWAP IS LESS THAN OR EQUAL TO $84.37, EXCHANGE RATIO WILL BE 0.06476 OF A BIONTECH ADS

Source text: ID:nGNX4Wp5vY

Further company coverage: [22UAy.DE]

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))